Contract manufacturing to see double-digit growth

Hold onto your hats: The global market for contract manufacturing is headed for speedy growth over the next few years. According to a new report from RNCOS, pharmaceutical contract manufacturing is poised to grow about 12 percent per year from 2010 to 2012.

Cost is one of the reasons, of course. Another is the fact that CMOs have built up a lot of manufacturing infrastructure, making more contract work possible. Then there's some companies' new business strategy: the "virtual pharma" that holds marketing rights to a product, but outsources production and the like.

Just where is that CMO business going? According to RNCOS, leading destinations are India, Brazil, Ukraine, Mexico, China and Singapore.

- see the RNCOS release

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.